Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”)...
EHR
JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five...
JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five...
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targetsThe agreement -...
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targetsThe agreement -...
2026 Regulatory Crossfire: New Outlook Survey Reveals Health IT Rules Reshaping U.S. Care Delivery
Black Book Research national survey maps federal, state, and local mandates impacting hospital, physician, and payer information technology in 2026...
Kontakt.io Introduces Access Agent to Boost Outpatient Clinic Efficiency By Up To 20% With AI
First-of-its-kind AI Agent provides real-time insights into exam room utilization, ensuring patients experience shorter wait times and more timely appointments.Integration...
CISOs in 9 Countries: Vendor AI and EHR Now Drive Most Healthcare Data Breaches
New Black Book Research flash survey of 427 hospital and health system security leaders finds 74% see EHR, AI and...
ChiroTouch Unveils Compliance Scan, Delivering AI-Powered Documentation Accuracy and Audit Protection to Chiropractors
SAN DIEGO--(BUSINESS WIRE)--#ChiroTouch--Claim denials and documentation errors can drain up to 30% of a chiropractic practice’s expected collections, creating significant...
Nordic Recognized as Major Contender in Healthcare IT Services by Everest Group
MADISON, Wis., Dec. 8, 2025 /PRNewswire/ -- Nordic®, a global health and technology consulting company, is named a Major Contender...
ECP Completes Massive Growth Financing to Accelerate Investment in AI Platform for Assisted Living
MILWAUKEE--(BUSINESS WIRE)--#assistedliving--ECP, the leading software platform purpose-built for assisted living, announced today a significant growth investment from software specialist Level...
Welldoc Partners with CLEAR to Integrate Secure Identity Verification in AI-Powered Cardiometabolic Health Platform
Collaboration Advances CMS Health Tech Ecosystem Goals by Enabling Seamless, Secure Access to Health Data for Personalized Chronic Disease Management...
Clinical Communication & Collaboration Market worth $5,302.9 million by 2030 | MarketsandMarkets™
DELRAY BEACH, Fla., Dec. 8, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the Clinical Communication & Collaboration Market is projected to grow...
Europe’s Hospitals Can’t Cut Off Hacked Vendors Fast Enough, New Cyber Report Warns
Black Book Research's Europe Cybersecurity in Healthcare 2026 finds only 13% of providers have tested kill-switches for critical vendors and...
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab and lenalidomide (EPKINLY+ R2) resulted...
Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines
Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform and presenting rare disease AI...
Avantor® Appoints Sanjeev Mehra to its Board of Directors
RADNOR, Pa., Dec. 4, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services...
HaloMD Expands Executive Leadership to Further Strengthen Industry-Leading Data, Technology, and Compliance Operations as Independent and Rural Practices Continue to Face Operational Risk
ADDISON, Texas, Dec. 4, 2025 /PRNewswire/ -- HaloMD today announced the addition of three established executive experts across data, technology, and...
Medi-Weightloss Celebrates 10 Million Pounds Lost, Improving Lives and Reducing Healthcare Costs
A leader in medically supervised weight management, proudly announces a major milestone: more than 10 million pounds lost collectively by...
Paradigm Health Acquires Flatiron Health’s Clinical Research Business and Forms Strategic Partnership to Rebuild Clinical Research Ecosystem
Partnership creates the largest oncology research network in the United States, enabling clinical trials to reach rural and community-based practices...